drugset / Trial / NCT02576041

Effects of Bilastine on F1 Simulator Driving Performance in Patients Affected by Allergic Rhinitis and/or Urticaria

NCT02576041

Phase 4 Completed 19 enrolled Menarini International Operations Luxembourg SA
NaSingle-groupOpen-labelSupportive care

Summary

The aim of the study is to evaluate the effects of Bilastine on patients' attention and reactivity levels by measuring psychophysical performance at a F1-high speed simulator driving test.

Timeline

Start
2015-10
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Bilastine Small molecule